Creating business success from life sciences
Tissue 'scaffold' team win award
03/12/2008
07:43
Article by Nottingham Evening Post
A University of Nottingham medical company has been honoured with a top award for innovation.
RegenTec, led by Professor Kevin Shakesheff and Dr Robin Quirk at BioCity, specialises in regenerative medicine.
It has developed a family of 'scaffolds' which allow human tissue to grow where the body's natural repair processes have failed.
The scaffolds solidify within the body and can be used to support tissue growth to minimise the need for invasive surgery.
Officials say the technology has the potential to revolutionise healthcare by providing permanent replacements for damaged or diseased tissue.
The company was this week honoured at the Medical Futures Innovation Awards 2008 in London.
Prof Shakesheff, the company's scientific director, said the award was recognition of the "dedication of our teams in the university and in Biocity Nottingham".
He said: "We believe our technology will be used throughout the world to make orthopaedic surgery quicker, cheaper and more effective."
- 16/05/2013 Winner of Kelly Services 2012 Global Supplier Excellence Award CK Associates are thrilled to announce they have been presented with the exclusive 2012 Supplier Excellence Award for Science by Kelly Services at the official ceremony held last night in London. Jonathan Hart Smith, MD of CK Associates, said, “Having supported Kelly Services with scientific recruitment since 2007 we are honoured to have been recognised for our hard work and hope this sees the continuation of a great partnership.” Read this article
- 07/05/2013 BioCity to develop BioHub at Alderley Park BioCity Nottingham Ltd, the UK’s leading provider of life sciences business incubation services, has been appointed by AstraZeneca to establish a new centre for bioscience companies at Alderley Park in Cheshire. The BioHub, will initially provide 36,000 sq ft of high-end laboratory and office facilities for early-stage and growing firms engaged in innovative drug discovery and development. Demand for accommodation is expected to be competitive with the first three tenant companies due to move on site today. Read this article
